186 related articles for article (PubMed ID: 25261416)
1. In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
López Y; Tato M; Espinal P; Garcia-Alonso F; Gargallo-Viola D; Cantón R; Vila J
J Antimicrob Chemother; 2015 Jan; 70(1):57-61. PubMed ID: 25261416
[TBL] [Abstract][Full Text] [Related]
2. Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values.
Tato M; López Y; Morosini MI; Moreno-Bofarull A; Garcia-Alonso F; Gargallo-Viola D; Vila J; Cantón R
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):263-7. PubMed ID: 24321353
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
Kanayama S; Okamoto K; Ikeda F; Ishii R; Matsumoto T; Hayashi N; Gotoh N
J Infect Chemother; 2017 Jun; 23(6):374-380. PubMed ID: 28389164
[TBL] [Abstract][Full Text] [Related]
4. Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis.
López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I
PLoS One; 2019; 14(10):e0223326. PubMed ID: 31596898
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
6. In vitro development of resistance to DX-619 and other quinolones in enterococci.
Wickman PA; Black JA; Smith Moland E; Thomson KS; Hanson ND
J Antimicrob Chemother; 2006 Dec; 58(6):1268-73. PubMed ID: 17062613
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
8. Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.
Remy JM; Tow-Keogh CA; McConnell TS; Dalton JM; Devito JA
J Antimicrob Chemother; 2012 Dec; 67(12):2814-20. PubMed ID: 22875850
[TBL] [Abstract][Full Text] [Related]
9. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
Davies TA; Yee YC; Goldschmidt R; Bush K; Sahm DF; Evangelista A
J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
Lister PD
Postgrad Med; 2008 Sep; 120(3 Suppl 1):46-52. PubMed ID: 18931471
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.
Canton R; Morrissey I; Vila J; Tato M; García-Castillo M; López Y; Gargallo-Viola D; Zsolt I
Future Microbiol; 2018 May; 13():3-19. PubMed ID: 29745242
[TBL] [Abstract][Full Text] [Related]
12. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
Avrain L; Garvey M; Mesaros N; Glupczynski Y; Mingeot-Leclercq MP; Piddock LJ; Tulkens PM; Vanhoof R; Van Bambeke F
J Antimicrob Chemother; 2007 Nov; 60(5):965-72. PubMed ID: 17693451
[TBL] [Abstract][Full Text] [Related]
13. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Xu X; Wu S; Ye X; Liu Y; Shi W; Zhang Y; Wang M
Antimicrob Agents Chemother; 2007 Nov; 51(11):4105-10. PubMed ID: 17724159
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
18. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
19. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
